KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

3 Biotech Stocks That Surged in September

07:39am, Tuesday, 05'th Oct 2021
Find out why last month was a big one for these three drugmakers.
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion pro
NEW YORK, Sept. 30, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights
Sanofi (SNY), Pfizer (PFE) and Novo Nordisk (NVO) are three large drugmakers that are worth betting on in the current scenario.
NEW YORK, Sept. 13, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class A

Kadmon, The Big Short

01:22am, Thursday, 09'th Sep 2021
Kadmon, The Big Short
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Kadmon Holdings, Inc. (NASDAQ: KDMN) to Sanofi for $9.50 per share in cash is fair

KDMN Stock: Why It Surged Today

08:54pm, Wednesday, 08'th Sep 2021
The stock price of Kadmon Holdings Inc (NASDAQ: KDMN) increased 71.13% today. This is why it The post KDMN Stock: Why It Surged Today appeared first on Pulse 2.0.
MILWAUKEE, Sept. 8, 2021 /PRNewswire/ -- Ademi LLP is investigating Kadmon (NASDAQ:KDMN), for possible breaches of fiduciary duty and other violations of law in its transaction with Sanofi.
Sanofi (SNY) offers $1.9 billion to buy Kadmon Holdings to strengthen its transplant business.
Sanofi adds another bolt-on acquisition in what is turning out to be a busy year for the French pharma titan.
Dear recipient,Please note this is a corrected french version of the release which replaces the release sent on September 8 at 8.31 am Paris time where the word « … relutif» has been replaced wit
French drugmaker Sanofi is buying Kadmon, the U.S. biopharmaceutical company, for a total equity value of $1.9 billion.
Underlining the focus on inorganic growth, French pharma giant Sanofi (NASDAQ: SNY) announced a big-ticket acquisition just a month after another billion-dollar deal. Sanofi-Kadmon Deal Terms: Sano
The stock price of Kadmon Holdings Inc (NASDAQ: KDMN) increased by over 75% pre-market. This is why it happened.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE